Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NARF antisense RNA 1 (NARF-AS1)
- Target
- NARF-AS1
- Molecular classification
- Long noncoding RNA (lncRNA), Natural antisense transcript (NAT)
01
Overview
NARF antisense RNA 1 (NARF-AS1) is a human long noncoding natural antisense transcript, transcribed from the strand opposite the NARF gene. Like other antisense lncRNAs, it does not encode a protein and is thought to act primarily in gene regulation, possibly influencing expression of overlapping or neighboring protein-coding genes through various transcriptional or epigenetic mechanisms. Its exact function remains uncharacterized, and no evidence currently links it to direct disease, biomarker, or druggable target status.
- Other names
- NARF-AS1NARF antisense RNA 1ENST00000582249.1
02
Biological functions
Regulation of gene expression (cis- and trans-acting modulation)Potential modulation of chromatin statePossible involvement in epigenetic regulation (general to NATs/AS-lncRNAs)
03
Disease associations
Other (No direct evidence linking NARF-AS1 to major disease classes in curated human disease databases as of 2024; related lncRNAs sometimes implicated in cancers or epigenetic disease, but no direct role established for NARF-AS1)
Beyond the preview
Go deeper on NARF antisense RNA 1 (NARF-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NARF antisense RNA 1 (NARF-AS1).